Platform terms
Document status
Draft for legal and operational review · Updated 28 August 2026
Mapping the supply route
These draft terms describe the intended boundaries of the B2B enquiry platform. They are non-indexable until legal-entity and jurisdictional review is complete.
The website is designed for business-to-business pharmaceutical and medical-supply procurement enquiries. It is not a pharmacy, prescribing service, patient-care service, or source of medical advice.
Users must act for a legitimate organization and provide accurate, relevant business information.
Draft product, category, destination, solution, and editorial pages do not establish availability, price, therapeutic suitability, registration, certification, import eligibility, or a guaranteed service route.
Market and product information must be verified for the exact request before reliance or commercial use.
Submitting an enquiry does not create an order, supply obligation, agency relationship, exclusivity arrangement, or binding offer. Any commercial response remains subject to verification, written scope, and acceptance through an authorized process.
Users must not submit patient data, payment-card data, credentials, unlawful requests, or confidential information that is not necessary for procurement review.
Entity identity, governing law, dispute terms, liability provisions, intellectual-property terms, suspension rights, and formal notice details will be completed before these terms are published.
Until then, this page communicates product boundaries for platform review and should not be treated as an executed agreement.